Grand Rounds archives 2021
Researchers
(virtual) Grand Rounds in Thoracic Surgery at the Royal Brompton Hospital
Connecting world leaders to a world of learners
This is the collection of the fantastic talks and discussions from our series.
2021 grand rounds
Friday 4 December 2020, 08:00
Professor Eric Lim, Royal Brompton Hospital
Evidence for VATS lobectomy: VIOLET in context
Professor Lim, Chief Investigator of VIOLET will be presenting the evidence generated in the context of existing published trials.
Friday 11 December 2020, 08:00
Dr Philip Crosbie, Wythenshaw Hospital
Predicting lung cancer threshold risks
Dr Crosbie, Chief Investigator of the NIHR Early detection Lung Pilot will be discussing his work on lung cancer risk modelling used for entry for lung screening.
Friday 18 December 2020, 08:00
Professor Harry de Koning, Erasmus MC
Lung cancer screening - summary of the evidence
Professor de Koning, Chief Investigator of NELSON will present the latest evidence from trials of lung cancer screening.
Friday 8 January 2021, 08:00
Professor Walter Weder, Thoraxchirurgie Bethanien
Lung volume reduction - when is surgery better than bronchosocpic volume reduction?
Professor Weder will be presenting his views on when surgical volume reduction is better than bronchoscopic techniques.
Friday 15 January 2021, 08:00
Professor Pallav Shah, Royal Brompton Hospital
Lung volume reduction: when is bronchoscopic volume reduction better than surgery?
Professor Shah will be presenting the counterpoints when bronchoscopic techniques are more appropriate for volume resection.
Friday 22 January 2021
Dr Alex Brunelli, St James Hospital
Risk assessment for dyspnoea undergoing lung resection
Dr Brunelli, Chair of the ESTS guidelines will present the formulation on risk assessment for dyspnoea for lung resection.
Friday 5 February 2021, 08:00
Professor Suresh Senan, VU University Medical Center
Early stage NSCLC: surgery or SABR for resectable disease?
Professor Senan, Chief Investigator of many radiation oncology trials including ROSEL will present his views on SABR in resectable lung cancer.
Friday 12 February 2021, 08:00
Professor Isabelle Opitz, University Hospital Zurich
Mesothelioma: the role of surgery
Professor Opitz, Chair of the ESMO Guidelines will present her views on the role of radical surgery for mesothelioma.
Friday 26 February 2021, 08:00
Professor Eric Lim, Royal Brompton Hospital
Locally advanced NSCLC: optimum management for IIIA/N2 disease
Professor Lim, will present latest recommendation from the UK and rest of the world on optimal management
Friday 5 March 2021, 08:00
Dr Robert Rintoul, Royal Papworth Hospital
Locally advanced NSCLC: is there still a role for mediastinal staging in lung cancer?
Dr Rintoul, Chief Investigator of ASTER will present the utility of EBUS lymph node staging in light of current clinical guidelines
12 March 2021, 08:00
Professor Paul Van Schil, University Hospital of Antwerp
Advanced NSCLC: optimum management of synchronous tumours
Professor Van Schil will present on management options on the difficult clinical decision of patients presenting with two nodules
19 March 2020, 08:00
Dr Diego Gonzalez, Coruña University and Shanghai Pulmonary Hospitals
Early NSCLC: how to manage vascular injuries
A technical session presented by the world renown master of uniportal surgery.
9 APRIL 2021, 08:00
PROFESSOR NICK MASKELL, NORTH BRISTOL NHS TRUST
Optimal medical management of pleural empyema
Professor Maskell, Co-Chair of the British Thoracic Society Pleural Guidelines will be discussing the evidence for medical management of empyema.
16 APRIL 2021, 08:00
PROFESSOR ENRICO RUFFINI, UNIVERSITY OF TORINO
Developing a TNM staging system for thymoma
Professor Ruffini, President of the ESTS and Chair of the TNM 9 thymic subcommittee will be presenting the rationale for TNM staging in thymoma.
23 APRIL 2021, 08:00
PROFESSOR VINCENT FANG, SHANGHAI CHEST HOSPITAL
Evidence for minimal access surgery for thymic tumours
Professor Fang, will be presenting unique insights from China on long term outcomes of minimal access surgery for thymic tumours.
30 APRIL 2021, 08:00
DR FERGUS MACBETH
Pulmonary colorectal metastases: is there any role for surgery?
Dr MacBeth from the PulMiCC trials committee discusses the published findings of PulMiCC in light of existing evidence.
7 MAY 2021, 08:00
DR ALAN SIHOE, GLENEAGLES HOSPITAL, HONG KONG
Management of screen detected GGO <3cm
Dr Sihoe will be presenting an South-East Asian perspective on the management of screen detected ground glass opacities
14 MAY 2021, 08:00
PROF PETER LICHT, SOUTHERN DANISH UNIVERSITY
Pneumothorax: is surgery required for the first episode?
Prof Licht, President of EACTS will present finding from his RCT on the utility of surgery for first episode of a pneumothorax
21 MAY 2021, 08:00
MR IAN HUNT, ST GEORGE’S UNIVERSITY HOSPITAL
Advances in the management of pectus deformities
Mr Hunt will present an overview of options and outcomes for the management of pectus deformities
28 may 2021, 08:00
prof Pierre-Emmanuel Falcoz, Strasbourg University Hospital
Operative surgery: advances in risk assessment for death
Professor Falcoz, who derived and published Thoracoscore will present an update on risk assessment (of death) in thoracic surgery
4 JUN 2021, 12:00 (UK) / 07:00 (NY)
PROFESSOR SHANDA BLACKMON, MAYO CLINIC
3D anatomic modelling to assist complex thoracic surgery
Professor Blackmon will share her expertise in 3D modelling to assist in pre-operative planning of complex surgery.
11 JUN 2021, 12:00 (UK) / 07:00 (NY)
PROFESSOR BRENDON STILES, MONTEFIORE MEDICAL CENTER
Optimal extent of resection for tumour <2cm?
Professor Stiles, will present his views on optimal resection of lung tumours less than 2cm with today’s evidence and in light of future clinical trials.
18 JUN 2021, 12:00 (UK) / 07:00 (NY)
PROFESSOR ROBERT CERFOLIO, NYU LANGONE HEALTH
Future leadership of robotic and thoracic surgery
Professor Cerfolio, will present his views robotic surgery, as well as an overview of future leadership in thoracic surgery
25 JUN 2021, 12:00 (UK) / 07:00 (NY)
DR STEPHEN CASSIVI, MAYO CLINIC
Chest wall surgery: options for reconstructive surgery for malignant disease
Dr Cassivi , will present his expertise in chest wall surgery giving an overview of options for reconstruction.
2 JUL 2021, 12:00 (UK) / 07:00 (NY)
DR JAMES HUANG, MEMORIAL SLOAN KETTERING CANCER CENTER
Challenges and controversies for lymph node staging in TNM9
Dr Huang, Chair of the N category sub-group of TNM 9 will present an overview on lymph node staging and proposals on future developments
9 Jul 2021, 12:00 (UK) / 07:00 (NY)
dr jonathan spicer, McGill university health centre
Neoadjuvant immunotherapy for early lung cancer
Following his highly influential presentation Checkmate 816 at ASCO, Dr Spicer (thoracic surgeon) will present his views on IO for early lung cancer.
16 JUL 2021, 12:00 (UK) / 07:00 (NY)
DR MARA ANTONOFF, MD ANDERSON CANCER CENTRE
Surgical multimodality local consolidation for advanced lung cancer
Based on work at MD Anderson, Dr Antonoff will present her views on surgery as part of multimodality management in advanced lung cancer.
6 AUG 2021, 08:00 (UK)
DR AJLAN ATASOY, ASTRAZENECA
Adjuvant EGFR TKI after complete resection of lung cancer - insights into ADAURA
Dr Atasoy from AstraZeneca will be presenting insights into the results and design of ADAURA
13 AUG 2021, 08:00 (UK)
MR JOEL DUNNING, SOUTH TEES HOSPITAL
Clinical implications for JCOG 0802
Mr Dunning will be discussing the recently presented results of JCOG 0802 (RCT of segmentectomy versus lobectomy) on clinical practice
3 SEP 2021, 08:00 (UK)
PROF PAUL BAAS, NETHERLANDS CANCER INSTITUTE
Immunotherapy for mesothelioma
Professor Baas will be presenting the latest practice changing clinical trial results on immunotherapy for mesothelioma.
17 SEP 2021, 08:00 (UK)
PROF NAJIB RAHMAN, UNIVERSITY OF OXFORD
Are chest drains required for primary spontaneous pneumothoraces?
Professor Rahman, based at the Nuffield Department of Medicine and current BTS co-chair for pleural diseases will present the up to date evidence and his views whether chest drains are required for primary spontaneous pneumothoraces.
24 SEP 2021, 08:00 (UK)
DR SHAUNAK NAVALKISSOOR, ROYAL FREE HOSPITAL
Imaging thoracic neuroendrocrine tumours
Dr Navalkissoor, current chair of the BIR Nuclear Medicine and Molecular Imaging will give an update on the imaging of Neuroendocrine tumours (NETs) to discuss comparative modalities for staging
01 OCT 2021, 08:00 (UK)
PROFESSOR PIER LUIGI FILOSSO, UNIVERSITY OF TORINO, ITALY
Thymic neuroendocrine tumours
Professor Filosso at University of Torino in Italy, chair of ESTS Lung NETs Working Group will present an update on the management of thymic neuroendocrine tumours.
22 OCT 2021, 08:00 (UK)
PROFESSOR CALVIN NG, THE CHINESE UNIVERSITY OF HONG KONG
Nodule isolation of surgery
Professor Ng, based at Prince of Wales Hospital in Hong Kong and a surgical pioneer in pre-operative localisation methods will give an update on nodule isolation prior to surgery.
29 OCT 2021, 08:00 (UK)
DR CARLOS ARTETA, OPTELLUM
Advances in AI for the diagnosis of lung cancer
Dr Arteta, Lead scientist at Optellum present recent advances and methodology on how machine learning for the diagnosis of lung cancer.
05 NOV 2021, 08:00 (UK)
DR SHUNICHI WATANABE, NATIONAL CANCER CENTRE, JAPAN
Significance and strategy of lymph node dissection for lung cancer
Dr Watanabe, a renowned cancer thoracic surgeon at National Cancer Centre in Japan and Chair of the TNM9 lymph node classification sub-committee will discuss the strategy of lymph node dissection.
12 NOV 2021, 08:00 (UK)
MR KOSTAS PAPAGIANNOPOULOS, ST JAMES’ UNIVERSITY HOSPITAL, LEEDS
Indications and techniques for tracheo- bronchoplasty
Mr Papagiannopoulos, past president of the ESTS and consultant thoracic surgeon will present the indications and techniques for trancheo-bronchoplasty.
26 NOV 2021, 08:00 (UK)
MR KELVIN LAU, BARTS HEALTH NHS TRUST
Endobronchial ablation therapy
Mr Lau, clinical lead in thoracic surgery at St Bartholomew’s Hospital who led his team to perform the one of the first endobronchial microwave ablation of lung tumour will present on endobronchial therapies.
03 DEC 2021, 08:00 (UK)
PROFESSOR VIRGINIE WESTEEL, UNIVERSITY OF FRANCHE-COMTE, FRANCE
CT follow up of patients after surgery
Professor of Pulmonology and head of the Thoracic Oncology unit in Besancon France, and chief investigator of IFCT-0302 will present evidence on CT scan-based follow up of patients after surgery for lung cancer.
10 DEC 2021, 08:00 (UK)
DR CECILIA POMPILI, UNIVERSITY OF LEEDS
e-Patient reported outcomes after lung surgery
Dr Pompili, academic thoracic surgeon at Leeds Institute of Cancer & Pathology will discuss e-Patient reported outcomes after lung surgery.